Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (221-230 of 484) with videos related to

Pageof 49
Sort By:
JAMA Oncology|July 17, 2015
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Wendy E Barrington, Jeannette M Schenk, Ruth Etzioni, et al.
Controlled Clinical Trials|March 17, 2004
Implementation of the Prostate Cancer Prevention Trial (PCPT)Phyllis J Goodman, Catherine M Tangen, John J Crowley, et al.
JAMA|July 7, 2005
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lowerIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
European Urology Focus|March 21, 2026
Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein ModelEmily A Vertosick, Phyllis Goodman, Catherine M Tangen, et al.
Urology|September 18, 2009
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepositoryLisa F Newcomb, James D Brooks, Peter R Carroll, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2013
The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancerEdward A Medina, Xiaoyu Shi, Marcia H Grayson, et al.
Endocrine-Related Cancer|December 10, 2021
Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trialCindy H Chau, Cathee Till, Douglas K Price, et al.
The New England Journal of Medicine|August 16, 2013
Long-term survival of participants in the prostate cancer prevention trialIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
The Journal of Urology|October 24, 2002
Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic menIvana Balic, Stanley T Graham, Dean A Troyer, et al.
The Journal of Urology|May 15, 2007
Finasteride decreases the risk of prostatic intraepithelial neoplasiaIan M Thompson, M Scott Lucia, Mary W Redman, et al.
Pageof 49

Showing results (221-230 of 484) with videos related to

Sort By:
Pageof 49
JAMA Oncology|July 17, 2015
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Wendy E Barrington, Jeannette M Schenk, Ruth Etzioni, et al.
Controlled Clinical Trials|March 17, 2004
Implementation of the Prostate Cancer Prevention Trial (PCPT)Phyllis J Goodman, Catherine M Tangen, John J Crowley, et al.
JAMA|July 7, 2005
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lowerIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
European Urology Focus|March 21, 2026
Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein ModelEmily A Vertosick, Phyllis Goodman, Catherine M Tangen, et al.
Urology|September 18, 2009
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepositoryLisa F Newcomb, James D Brooks, Peter R Carroll, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2013
The diagnostic value of adiponectin multimers in healthy men undergoing screening for prostate cancerEdward A Medina, Xiaoyu Shi, Marcia H Grayson, et al.
Endocrine-Related Cancer|December 10, 2021
Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trialCindy H Chau, Cathee Till, Douglas K Price, et al.
The New England Journal of Medicine|August 16, 2013
Long-term survival of participants in the prostate cancer prevention trialIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
The Journal of Urology|October 24, 2002
Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic menIvana Balic, Stanley T Graham, Dean A Troyer, et al.
The Journal of Urology|May 15, 2007
Finasteride decreases the risk of prostatic intraepithelial neoplasiaIan M Thompson, M Scott Lucia, Mary W Redman, et al.
Pageof 49